(Reuters) - Omeros Corp said the U.S. Food and Drug Administration had approved its drug for use in cataract and lens replacement surgeries, making it the company's first drug to be approved by the regulator. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/-TvNpt3Sgeo/story01.htm
Read More
No comments:
Post a Comment